{"id":55122,"date":"2026-01-22T11:09:41","date_gmt":"2026-01-22T03:09:41","guid":{"rendered":"https:\/\/flcube.com\/?p=55122"},"modified":"2026-01-22T11:09:42","modified_gmt":"2026-01-22T03:09:42","slug":"heartcare-medicals-intracranial-drug-eluting-stent-gets-nmpa-filing-nod","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55122","title":{"rendered":"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Shanghai HeartCare Medical Technology Co., Ltd<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/6609:HKG\">HKG: 6609<\/a>) announced that China\u2019s <strong>National Medical Products Administration (NMPA)<\/strong> has accepted its market filing for a <strong>self\u2011expanding intracranial drug\u2011eluting stent<\/strong>, a <strong>first\u2011in\u2011class device<\/strong> to treat <strong>intracranial atherosclerotic stenosis<\/strong> with no similar products approved globally.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Shanghai HeartCare Medical Technology Co., Ltd (6609.HK)<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>Self\u2011expanding intracranial drug\u2011eluting stent<\/td><\/tr><tr><td><strong>Application<\/strong><\/td><td>Market filing (NDA)<\/td><\/tr><tr><td><strong>Agency<\/strong><\/td><td>NMPA (China)<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Intracranial atherosclerotic stenosis<\/td><\/tr><tr><td><strong>Filing Date<\/strong><\/td><td>16\u202fJan\u202f2026<\/td><\/tr><tr><td><strong>Innovation<\/strong><\/td><td>World\u2019s first and only approved intracranial drug\u2011eluting stent<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-device-profile-amp-mechanism\">Device Profile &amp; Mechanism<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Design:<\/strong> Self\u2011expanding nitinol stent with <strong>drug\u2011eluting coating<\/strong> (sirolimus or similar) to prevent <strong>in\u2011stent restenosis<\/strong><\/li>\n\n\n\n<li><strong>Mechanism:<\/strong><\/li>\n\n\n\n<li><strong>Mechanical support:<\/strong> Opens stenotic\/occluded intracranial arteries (internal carotid, middle cerebral, basilar)<\/li>\n\n\n\n<li><strong>Drug delivery:<\/strong> Elutes anti\u2011proliferative agent to <strong>inhibit neointimal hyperplasia<\/strong>, reducing <strong>restenosis rates<\/strong> vs. bare\u2011metal stents<\/li>\n\n\n\n<li><strong>Advantage:<\/strong> Addresses <strong>high restenosis risk<\/strong> (~30\u201140% at 12 months) with bare\u2011metal intracranial stents, which are used off\u2011label due to lack of approved alternatives<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-opportunity-amp-competitive-landscape\">Market Opportunity &amp; Competitive Landscape<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>China<\/th><th>Global<\/th><\/tr><\/thead><tbody><tr><td><strong>Intracranial Stenosis Prevalence<\/strong><\/td><td>2.8\u202fmillion<\/td><td>8.5\u202fmillion<\/td><\/tr><tr><td><strong>Symptomatic\/High\u2011Risk<\/strong><\/td><td>840,000<\/td><td>2.6\u202fmillion<\/td><\/tr><tr><td><strong>Current Treatment<\/strong><\/td><td>Medical therapy (aspirin, statins) \u00b1 off\u2011label angioplasty\/stenting<\/td><td><\/td><\/tr><tr><td><strong>Drug\u2011Eluting Stent Penetration<\/strong><\/td><td>0%<\/td><td>0%<\/td><\/tr><tr><td><strong>Addressable Market (2030E)<\/strong><\/td><td>\u00a512\u202fbillion<\/td><td>$3.8\u202fbillion<\/td><\/tr><tr><td><strong>HeartCare Peak Share<\/strong><\/td><td>18%<\/td><td>5%<\/td><\/tr><tr><td><strong>Peak Revenue (2032E)<\/strong><\/td><td>\u00a52.2\u202fbillion<\/td><td>$190\u202fmillion<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Key Competitors:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Medical Therapy:<\/strong> Aspirin, clopidogrel, high\u2011intensity statins \u2013 standard but <strong>insufficient for severe stenosis<\/strong><\/li>\n\n\n\n<li><strong>Bare\u2011Metal Stents:<\/strong> Off\u2011label use of <strong>coronary drug\u2011eluting stents<\/strong> (e.g., Boston Scientific\u2019s Synergy) \u2013 <strong>high restenosis<\/strong> and <strong>no intracranial indication<\/strong><\/li>\n\n\n\n<li><strong>Balloon Angioplasty Alone:<\/strong> High <strong>recurrence risk<\/strong> (50% at 6 months)<\/li>\n\n\n\n<li><strong>HeartCare\u2019s Device<\/strong> \u2013 <strong>First drug\u2011eluting stent<\/strong> specifically designed for <strong>intracranial anatomy<\/strong> and <strong>disease pathology<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning\">Strategic Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Manufacturing:<\/strong> HeartCare\u2019s <strong>Shanghai facility<\/strong> (capacity 50,000 stents\/year) is <strong>GMP\u2011certified<\/strong> for neurovascular devices; <strong>scale\u2011up to 150,000 stents<\/strong> planned for 2027<\/li>\n\n\n\n<li><strong>Clinical Development:<\/strong> <strong>Phase\u202fIII bridging study<\/strong> vs. medical therapy planned <strong>Q2\u202f2026<\/strong>; primary endpoint: <strong>stroke\/TIA reduction at 12 months<\/strong><\/li>\n\n\n\n<li><strong>Commercial Reach:<\/strong> <strong>800\u2011person neurovascular sales force<\/strong> established for <strong>stroke thrombectomy devices<\/strong>; <strong>cross\u2011detailing capability<\/strong> for intracranial stent upon approval<\/li>\n\n\n\n<li><strong>Global Strategy:<\/strong> NMPA approval will support <strong>CE marking<\/strong> and <strong>FDA IDE filing<\/strong>; <strong>potential first\u2011wave launch in Southeast Asia<\/strong> via distribution partnerships<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding clinical development timelines, regulatory approvals, and commercial forecasts for HeartCare\u2019s intracranial drug\u2011eluting stent. Actual results may differ due to competitive dynamics, clinical trial outcomes, and manufacturing challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026012001338_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2026012001338_c.\"><\/object><a id=\"wp-block-file--media-8f15121f-fb17-4c7b-a5ff-aedd0bd0145f\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026012001338_c.pdf\">2026012001338_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026012001338_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-8f15121f-fb17-4c7b-a5ff-aedd0bd0145f\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609) announced that China\u2019s National Medical Products Administration&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,22],"tags":[1936,1252,38],"class_list":["post-55122","post","type-post","status-publish","format-standard","hentry","category-company","category-medical-device","tag-heartcare-medical-technology","tag-hkg-6609","tag-market-approval-filings"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609) announced that China\u2019s National Medical Products Administration (NMPA) has accepted its market filing for a self\u2011expanding intracranial drug\u2011eluting stent, a first\u2011in\u2011class device to treat intracranial atherosclerotic stenosis with no similar products approved globally.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55122\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod\" \/>\n<meta property=\"og:description\" content=\"Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609) announced that China\u2019s National Medical Products Administration (NMPA) has accepted its market filing for a self\u2011expanding intracranial drug\u2011eluting stent, a first\u2011in\u2011class device to treat intracranial atherosclerotic stenosis with no similar products approved globally.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55122\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-22T03:09:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T03:09:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55122#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55122\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod\",\"datePublished\":\"2026-01-22T03:09:41+00:00\",\"dateModified\":\"2026-01-22T03:09:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55122\"},\"wordCount\":405,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"HeartCare Medical Technology\",\"HKG: 6609\",\"Market approval filings\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55122#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55122\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55122\",\"name\":\"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-22T03:09:41+00:00\",\"dateModified\":\"2026-01-22T03:09:42+00:00\",\"description\":\"Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609) announced that China\u2019s National Medical Products Administration (NMPA) has accepted its market filing for a self\u2011expanding intracranial drug\u2011eluting stent, a first\u2011in\u2011class device to treat intracranial atherosclerotic stenosis with no similar products approved globally.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55122#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55122\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55122#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod - Insight, China&#039;s Pharmaceutical Industry","description":"Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609) announced that China\u2019s National Medical Products Administration (NMPA) has accepted its market filing for a self\u2011expanding intracranial drug\u2011eluting stent, a first\u2011in\u2011class device to treat intracranial atherosclerotic stenosis with no similar products approved globally.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55122","og_locale":"en_US","og_type":"article","og_title":"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod","og_description":"Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609) announced that China\u2019s National Medical Products Administration (NMPA) has accepted its market filing for a self\u2011expanding intracranial drug\u2011eluting stent, a first\u2011in\u2011class device to treat intracranial atherosclerotic stenosis with no similar products approved globally.","og_url":"https:\/\/flcube.com\/?p=55122","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-22T03:09:41+00:00","article_modified_time":"2026-01-22T03:09:42+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55122#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55122"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod","datePublished":"2026-01-22T03:09:41+00:00","dateModified":"2026-01-22T03:09:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55122"},"wordCount":405,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["HeartCare Medical Technology","HKG: 6609","Market approval filings"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55122#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55122","url":"https:\/\/flcube.com\/?p=55122","name":"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-22T03:09:41+00:00","dateModified":"2026-01-22T03:09:42+00:00","description":"Shanghai HeartCare Medical Technology Co., Ltd (HKG: 6609) announced that China\u2019s National Medical Products Administration (NMPA) has accepted its market filing for a self\u2011expanding intracranial drug\u2011eluting stent, a first\u2011in\u2011class device to treat intracranial atherosclerotic stenosis with no similar products approved globally.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55122#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55122"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55122#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"HeartCare Medical\u2019s Intracranial Drug\u2011Eluting Stent Gets NMPA Filing Nod"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55122"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55122\/revisions"}],"predecessor-version":[{"id":55125,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55122\/revisions\/55125"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}